Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-25-000205·IGM Biosciences, Inc.
Schedule 13G ownership disclosure
N/A
COMMON STOCK · CUSIP: 449585108
Event date: 2024-12-31
- Filing-level shares
- 3,568,999
- Percent of class
- 10.5%
- T. Rowe Price Associates, Inc.
Shares: 3,568,999 · Class: 10.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000205
- Form type
- SCHEDULE 13G/A
- Filer
- IGM Biosciences, Inc.
- CIK
- CIK 1496323
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership